DNA aptamers detecting generic amyloid epitopes

References

• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333 - 66; http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901; PMID: 16756495
   PubMed Web of Science ®Google Scholar
• Kajava AV, Squire JM, Parry DAD. β-structures in fibrous proteins. Adv Protein Chem 2006; 73:1 - 15; http://dx.doi.org/10.1016/S0065-3233(06)73001-7; PMID: 17190609
   PubMedGoogle Scholar
• Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996; 15:3127 - 34; PMID: 8670813
   PubMed Web of Science ®Google Scholar
• Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622 - 6; http://dx.doi.org/10.1126/science.273.5275.622; PMID: 8662547
   PubMed Web of Science ®Google Scholar
• Helsen CW, Glover JR. Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104). J Biol Chem 2012; 287:542 - 56; http://dx.doi.org/10.1074/jbc.M111.302869; PMID: 22081611
   PubMedGoogle Scholar
• Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG, et al. Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 1993; 7:683 - 92; http://dx.doi.org/10.1111/j.1365-2958.1993.tb01159.x; PMID: 8469113
   PubMed Web of Science ®Google Scholar
• Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae.. Genetics 1994; 137:671 - 6; PMID: 8088512
   PubMed Web of Science ®Google Scholar
• Cox BS, Tuite MF, McLaughlin CS. The psi factor of yeast: a problem in inheritance. Yeast 1988; 4:159 - 78; http://dx.doi.org/10.1002/yea.320040302; PMID: 3059716
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Derkach IL, Inge-Vechtomov SG. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae.. Curr Genet 1993; 24:268 - 70; http://dx.doi.org/10.1007/BF00351802; PMID: 8221937
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375 - 86; PMID: 8978027
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Masse SVL, Zadorsky SP, Polozkov GV, Inge-Vechtomov SG, et al. Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?. EMBO J 2000; 19:1942 - 52; http://dx.doi.org/10.1093/emboj/19.9.1942; PMID: 10790361
   PubMed Web of Science ®Google Scholar
• Kochneva-Pervukhova NV, Chechenova MB, Valouev IA, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. [Psi(+)] prion generation in yeast: characterization of the ‘strain’ difference. Yeast 2001; 18:489 - 97; http://dx.doi.org/10.1002/yea.700; PMID: 11284005
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. [PIN+] Cell 2001; 106:171 - 82; http://dx.doi.org/10.1016/S0092-8674(01)00427-5; PMID: 11511345
   PubMed Web of Science ®Google Scholar
• Krishnan R, Lindquist SL. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 2005; 435:765 - 72; http://dx.doi.org/10.1038/nature03679; PMID: 15944694
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 8; http://dx.doi.org/10.1038/nature02392; PMID: 15029196
   PubMed Web of Science ®Google Scholar
• Salnikova AB, Kryndushkin DS, Smirnov VN, Kushnirov VV, Ter-Avanesyan MD. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 2005; 280:8808 - 12; http://dx.doi.org/10.1074/jbc.M410150200; PMID: 15618222
   PubMed Web of Science ®Google Scholar
• King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319 - 23; http://dx.doi.org/10.1038/nature02391; PMID: 15029195
   PubMed Web of Science ®Google Scholar
• Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J 2005; 24:3082 - 92; http://dx.doi.org/10.1038/sj.emboj.7600772; PMID: 16096644
   PubMed Web of Science ®Google Scholar
• Patel BK, Liebman SW. “Prion-proof” for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. [PIN+] J Mol Biol 2007; 365:773 - 82; http://dx.doi.org/10.1016/j.jmb.2006.10.069; PMID: 17097676
   PubMed Web of Science ®Google Scholar
• Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636 - 43; http://dx.doi.org/10.1074/jbc.M307996200; PMID: 14507919
   PubMed Web of Science ®Google Scholar
• Kushnirov VV, Alexandrov IM, Mitkevich OV, Shkundina IS, Ter-Avanesyan MD. Purification and analysis of prion and amyloid aggregates. Methods 2006; 39:50 - 5; http://dx.doi.org/10.1016/j.ymeth.2006.04.007; PMID: 16774835
   PubMed Web of Science ®Google Scholar
• Syed MA, Pervaiz S. Advances in aptamers. Oligonucleotides 2010; 20:215 - 24; http://dx.doi.org/10.1089/oli.2010.0234; PMID: 20677985
   PubMed Web of Science ®Google Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505 - 10; http://dx.doi.org/10.1126/science.2200121; PMID: 2200121
   PubMed Web of Science ®Google Scholar
• Surina ER, Morozkina EV, Marchenko EV, Ter-Avanesian MD, Benevolenskiĭ SV, Kushnirov VV, et al. [Selection of DNA aptamers, specifically interacting with fibrillar form of the yeast Sup35 protein]. Mol Biol (Mosk) 2009; 43:682 - 8; http://dx.doi.org/10.1134/S0026893309040153; PMID: 19807032
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 48; http://dx.doi.org/10.1016/S0092-8674(00)81163-0; PMID: 9590169
   PubMed Web of Science ®Google Scholar
• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519 - 50; http://dx.doi.org/10.1146/annurev.neuro.24.1.519; PMID: 11283320
   PubMed Web of Science ®Google Scholar
• Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 2001; 29:15 - 32; http://dx.doi.org/10.1016/S0896-6273(01)00177-5; PMID: 11182078
   PubMed Web of Science ®Google Scholar
• Takahashi T, Katada S, Onodera O. Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going?. J Mol Cell Biol 2010; 2:180 - 91; http://dx.doi.org/10.1093/jmcb/mjq005; PMID: 20410236
   PubMed Web of Science ®Google Scholar
• Shkundina IS, Kushnirov VV, Tuite MF, Ter-Avanesyan MD. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants. Genetics 2006; 172:827 - 35; http://dx.doi.org/10.1534/genetics.105.048660; PMID: 16272413
   PubMed Web of Science ®Google Scholar
• Urakov VN, Vishnevskaya AB, Alexandrov IM, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions. Prion 2010; 4:45 - 52; http://dx.doi.org/10.4161/pri.4.1.11074; PMID: 20118659
   PubMed Web of Science ®Google Scholar
• Kochneva-Pervukhova NV, Alexandrov AI, Ter-Avanesyan MD. Amyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeast. PLoS One 2012; 7:e29832; http://dx.doi.org/10.1371/journal.pone.0029832; PMID: 22253794
   PubMedGoogle Scholar
• Zeiler B, Adler V, Kryukov V, Grossman A. Concentration and removal of prion proteins from biological solutions. Biotechnol Appl Biochem 2003; 37:173 - 82; http://dx.doi.org/10.1042/BA20020087; PMID: 12630906
   PubMed Web of Science ®Google Scholar
• Mercey R, Lantier I, Maurel MC, Grosclaude J, Lantier F, Marc D. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns. Arch Virol 2006; 151:2197 - 214; http://dx.doi.org/10.1007/s00705-006-0790-3; PMID: 16799875
   PubMed Web of Science ®Google Scholar
• Skrypina NA, Savochkina LP, Beabealashvilli RSh. In vitro selection of single-stranded DNA aptamers that bind human pro-urokinase. Nucleosides Nucleotides Nucleic Acids 2004; 23:891 - 3; http://dx.doi.org/10.1081/NCN-200026037; PMID: 15560078
   PubMed Web of Science ®Google Scholar
• Bunka DHJ, Mantle BJ, Morten IJ, Tennent GA, Radford SE, Stockley PG. Production and characterization of RNA aptamers specific for amyloid fibril epitopes. J Biol Chem 2007; 282:34500 - 9; http://dx.doi.org/10.1074/jbc.M703679200; PMID: 17878167
   PubMed Web of Science ®Google Scholar
• O’Nuallain B, Wetzel R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc Natl Acad Sci U S A 2002; 99:1485 - 90; http://dx.doi.org/10.1073/pnas.022662599; PMID: 11818542
   PubMed Web of Science ®Google Scholar
• Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 2002; 157:997 - 1004; http://dx.doi.org/10.1083/jcb.200112104; PMID: 12058016
   PubMed Web of Science ®Google Scholar
• Alexandrov IM, Vishnevskaya AB, Ter-Avanesyan MD, Kushnirov VV. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation. J Biol Chem 2008; 283:15185 - 92; http://dx.doi.org/10.1074/jbc.M802071200; PMID: 18381282
   PubMed Web of Science ®Google Scholar
• Wang P, Hatcher KL, Bartz JC, Chen SG, Skinner P, Picht J, et al. Selection and characterization of DNA aptamers against PrPSc. Exp Biol Med 2011; 236:466 - 76; http://dx.doi.org/10.1258/ebm.2011.010323
   Web of Science ®Google Scholar
• Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. [psi+] Science 1995; 268:880 - 4; http://dx.doi.org/10.1126/science.7754373; PMID: 7754373
   PubMed Web of Science ®Google Scholar
• Parham SN, Resende CG, Tuite MF. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 2001; 20:2111 - 9; http://dx.doi.org/10.1093/emboj/20.9.2111; PMID: 11331577
   PubMed Web of Science ®Google Scholar
• Urakov VN, Valouev IA, Kochneva-Pervukhova NV, Packeiser AN, Vishnevsky AY, Glebov OO, et al. N-terminal region of Saccharomyces cerevisiae eRF3 is essential for the functioning of the eRF1/eRF3 complex beyond translation termination. BMC Mol Biol 2006; 7:34; http://dx.doi.org/10.1186/1471-2199-7-34; PMID: 17034622
   PubMed Web of Science ®Google Scholar